11-Hydroxysteroid Dehydrogenase Type 1 (11HSD-1) GH is known to inhibit 11-hydroxysteroid dehydrogenase type 1 (11HSD-1), a microsomal enzyme required for conversion of cortisone to its active metabolite, cortisol, in hepatic and adipose tissue
Not because the symptoms are mild
Key Takeaways CagriSema and Retatrutide are both investigational: Neither is FDA-approved for obesity or diabetes treatment as of May 2026
But we also know that GLP-1 and weight loss injections injections in Basking Ridge, New Jersey, could make getting rid of stubborn excess weight easier and faster
Min, J., Sarlus, H., & Harris, R
Check out these blogs: GLP-1 Medications: How They Support Weight Loss & Health GLP-1 Meal Plan: A Guide to Good Nutrition While Taking GLP-1 Medications GLP-1 Receptor Activation for Appetite Suppression References 1